Mutations of the p53 tumor suppressor gene are the most frequent genetic lesion in breast cancer, suggesting a critical role for normal p53 protein in regulating mammary cell growth. The p53 mutations observed in various cancers have been shown to alter the biochemical functions of the p53 protein; however, it is not known which p53 functions are critical for its role in breast oncogenesis. Using the E6 oncogene of the human papilloma virus 16 (HPV16), they demonstrated that the loss of p53 protein was essential for immortalization of mammary epithelial cells (MECs). Recently, they have identified three p53 mutants, del239, R175H and R249S, which themselves are capable of inducing MEC immortalization, providing a unique system to delineate the p53 functions that are critical for MEC immortalization. Here, they propose analyses to elucidate the biochemical basis of mutant p53-induced MEC immortalization. Toward this goal we will (i) delineate the structural requirements for mutant p53-induced MEC immortalization by assessing the immortalizing ability of specific p53 mutants that alter its binding and transcriptional activation domains, (ii) analyze the effects of p53 mutants on p53-mediated transcriptional activation, repression, G1 arrest, and apoptosis. (iii) examine the in vivo association of p53 mutants with known cellular binding proteins. In particular, they propose to determine the primary structure of a del239 mutant-specific cellular binding protein p50 and to ascertain its role in mutant p53-induced immortalization. These studies, designed to identify the specific p53 functions that are targeted by immortalizing p53 mutants, should lead to a better understanding of how wild-type p53 controls normal MEC growth and how p53 mutations may contribute to the evolution of human breast cancer. Identification of novel targets of p53 function and oncogenesis in breast cells should be an important first step toward design of novel molecular therapeutics.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA070195-02
Application #
2837702
Study Section
Pathology B Study Section (PTHB)
Program Officer
Gallahan, Daniel L
Project Start
1997-12-12
Project End
2002-11-30
Budget Start
1998-12-01
Budget End
1999-11-30
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Tufts University
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02111
Ghosh, Amiya K; Reddi, Alagarsamy L; Rao, Navin L et al. (2004) Biochemical basis for the requirement of kinase activity for Cbl-dependent ubiquitinylation and degradation of a target tyrosine kinase. J Biol Chem 279:36132-41
Miura-Shimura, Yuko; Duan, Lei; Rao, Navin L et al. (2003) Cbl-mediated ubiquitinylation and negative regulation of Vav. J Biol Chem 278:38495-504
Singh, Latika; Gao, Qingshen; Kumar, Ajay et al. (2003) The high-risk human papillomavirus type 16 E6 counters the GAP function of E6TP1 toward small Rap G proteins. J Virol 77:1614-20
Zhou, Pengcheng; Fernandes, Norvin; Dodge, Ingrid L et al. (2003) ErbB2 degradation mediated by the co-chaperone protein CHIP. J Biol Chem 278:13829-37
Duan, Lei; Miura, Yuko; Dimri, Manjari et al. (2003) Cbl-mediated ubiquitinylation is required for lysosomal sorting of epidermal growth factor receptor but is dispensable for endocytosis. J Biol Chem 278:28950-60
Zeng, Musheng; Kumar, Ajay; Meng, Gaoyuan et al. (2002) Human papilloma virus 16 E6 oncoprotein inhibits retinoic X receptor-mediated transactivation by targeting human ADA3 coactivator. J Biol Chem 277:45611-8
Kumar, Ajay; Zhao, Yongtong; Meng, Gaoyuan et al. (2002) Human papillomavirus oncoprotein E6 inactivates the transcriptional coactivator human ADA3. Mol Cell Biol 22:5801-12
Gao, Qingshen; Kumar, Ajay; Singh, Latika et al. (2002) Human papillomavirus E6-induced degradation of E6TP1 is mediated by E6AP ubiquitin ligase. Cancer Res 62:3315-21
Dimri, Goberdhan P; Martinez, Jose-Luis; Jacobs, Jacqueline J L et al. (2002) The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells. Cancer Res 62:4736-45
Gao, Q; Singh, L; Kumar, A et al. (2001) Human papillomavirus type 16 E6-induced degradation of E6TP1 correlates with its ability to immortalize human mammary epithelial cells. J Virol 75:4459-66

Showing the most recent 10 out of 13 publications